{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:27:07Z","timestamp":1788798427503,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.urolonc.2008.08.003","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T05:02:04Z","timestamp":1225515724000},"page":"285-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Retinoblastoma protein expression predicts response to bacillus Calmette-Gu\u00e9rin immunotherapy in patients with T1G3 bladder cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"Luigi","family":"Cormio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Tolve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Annese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Saracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Zamparese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sanguedolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantaleo","family":"Bufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Selvaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2008.08.003_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000019664","article-title":"Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumors: Recurrence, progression, and success","volume":"34","author":"Lebret","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2008.08.003_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ucl.2005.02.002","article-title":"Optimal management of the T1G3 bladder cancer","volume":"32","author":"Manoharan","year":"2005","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2008.08.003_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-5347(17)39544-7","article-title":"The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS, and P2)","volume":"144","author":"Malkowicz","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.08.003_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","article-title":"Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?","volume":"166","author":"Herr","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2008.08.003_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0302-2838(03)00048-4","article-title":"Do prognostic parameters of remission versus relapse after bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy exist? Analysis of a quarter of century literature","volume":"43","author":"Saint","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2008.08.003_bib6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/jnci\/84.16.1256","article-title":"Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer","volume":"84","author":"Logothetis","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2008.08.003_bib7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jnci\/84.16.1251","article-title":"Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer","volume":"84","author":"Cordon-Cardo","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2008.08.003_bib8","first-page":"1090","article-title":"Elevated and absent pRB expression is associated with bladder cancer progression and has cooperative effects with p53","volume":"58","author":"Cote","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2008.08.003_bib9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2004.05.174","article-title":"Combined effects of p53, p21, and pRB expression in the progression of bladder transitional cell carcinoma","volume":"22","author":"Chatterjee","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2008.08.003_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2004.03.118","article-title":"p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer","volume":"22","author":"Shariat","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2008.08.003_bib11","first-page":"1217","article-title":"Cooperative effects of the p53 and pRB alterations in primary superficial bladder tumors","volume":"57","author":"Cordon-Cardo","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2008.08.003_bib12","first-page":"829","article-title":"P53 and RB expression predict progression in T1 bladder cancer","volume":"4","author":"Grossman","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2008.08.003_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjc.6601954","article-title":"Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16, and pRB","volume":"91","author":"Hitchings","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2008.08.003_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.cr.7290263","article-title":"Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress","volume":"15","author":"Wang","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.urolonc.2008.08.003_bib15","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1158\/0008-5472.CAN-05-1358","article-title":"Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation","volume":"65","author":"Ying","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2008.08.003_bib16","doi-asserted-by":"crossref","first-page":"9286","DOI":"10.1158\/0008-5472.CAN-07-2238","article-title":"Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation","volume":"67","author":"Ying","year":"2007","journal-title":"Cancer Res"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908002196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143908002196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:55:40Z","timestamp":1761040540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143908002196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1078143908002196"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.08.003","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinoblastoma protein expression predicts response to bacillus Calmette-Gu\u00e9rin immunotherapy in patients with T1G3 bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2008.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}